Aurobindo Pharma Quarterly Results - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Aurobindo Pharma Quarterly Results    (AUBD)

Here are the latest quarterly results of Aurobindo Pharma. For more details, see the Aurobindo Pharma financial fact sheet and Aurobindo Pharma share price and chart. For a sector overview, read our pharmaceuticals sector report.

Excel Export | Annual Financial Info | Result Scoreboard

Aurobindo Pharma Quarterly Results

No. of Mths
Qtr. Ending
3
Jun-18
*
3
Sep-18
*
3
Dec-18
*
3
Mar-19
*
3
Jun-19
*
3
Sep-19
*
3
Dec-19
*
3
Mar-20
*
8-Qtr Chart
Click to enlarge
Net Sales Rs m42,50347,51452,69752,92254,44656,00557,99461,584 
Other income Rs m437263639323158206309326 
Turnover Rs m42,94047,77753,33553,24554,60456,21158,30461,910 
Expenses Rs m35,39237,65141,83342,34742,98244,60346,87048,422 
Gross profit Rs m7,1119,59410,61310,21511,33711,27511,95113,285 
Depreciation Rs m1,5451,6371,6311,8662,4092,4332,5012,324 
Interest Rs m295354477501499409371318 
Profit before tax Rs m5,7077,8669,1448,1708,5878,6389,38810,968 
Tax Rs m1,1551,7542,0482,3112,2782,2442,3292,285 
Profit after tax Rs m4,5526,1127,0965,8596,3106,3957,0608,683 
Gross profit margin %16.720.220.119.320.820.120.621.6 
Effective tax rate %20.222.322.428.326.526.024.820.8 
Net profit margin %10.712.913.511.111.611.412.214.1 
Diluted EPS Rs 7.8 10.4 12.1 10.0 10.8 10.9 12.1 14.8  
Diluted EPS (TTM) Rs 40.3 37.4 39.4 40.4 43.4 43.9 43.8 48.6  
 Subscriber Feature                  
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Read: Aurobindo Pharma 4QFY20 Result Performance Review

More Pharmaceuticals Company Quarterly Results:   UNICHEM LAB  STRIDES PHARMA SCIENCE  NATCO PHARMA  WYETH LTD  SANOFI INDIA  

Compare AUROBINDO PHARMA With:   UNICHEM LAB  STRIDES PHARMA SCIENCE  NATCO PHARMA  WYETH LTD  SANOFI INDIA  

Compare AUROBINDO PHARMA With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

India's Import Embargo on Defence Items, June Quarter Results, and Top Buzzing Stocks Today(Pre-Open)

Extending gains to the third straight day, Indian share markets witnessed buying interest throughout the day yesterday, amid sustained foreign fund inflows and positive cues from global markets.

Views on news

AUROBINDO PHARMA Announces Quarterly Results (4QFY20); Net Profit Up 48.2% (Quarterly Result Update)

Jun 5, 2020 | Updated on Jun 5, 2020

For the quarter ended March 2020, AUROBINDO PHARMA has posted a net profit of Rs 9 bn (up 48.2% YoY). Sales on the other hand came in at Rs 62 bn (up 16.4% YoY). Read on for a complete analysis of AUROBINDO PHARMA's quarterly results.

AUROBINDO PHARMA Announces Quarterly Results (3QFY20); Net Profit Down 0.5% (Quarterly Result Update)

Feb 7, 2020 | Updated on Feb 7, 2020

For the quarter ended December 2019, AUROBINDO PHARMA has posted a net profit of Rs 7 bn (down 0.5% YoY). Sales on the other hand came in at Rs 58 bn (up 10.1% YoY). Read on for a complete analysis of AUROBINDO PHARMA's quarterly results.

AUROBINDO PHARMA 2018-19 Annual Report Analysis (Annual Result Update)

Nov 6, 2019 | Updated on Nov 6, 2019

Here's an analysis of the annual report of AUROBINDO PHARMA for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of AUROBINDO PHARMA. Also includes updates on the valuation of AUROBINDO PHARMA.

AUROBINDO PHARMA 2017-18 Annual Report Analysis (Annual Result Update)

Dec 19, 2018 | Updated on Dec 19, 2018

Here's an analysis of the annual report of AUROBINDO PHARMA for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of AUROBINDO PHARMA. Also includes updates on the valuation of AUROBINDO PHARMA.

More Views on News

Most Popular

Before You Buy Your First Electric Vehicle Consider Buying this Stock (Profit Hunter)

Jul 29, 2020

As competition intensifies in the electric vehicle space, only few will create huge wealth over the years.

Large Opportunities Are Coming Our Way

Aug 5, 2020

Kenneth Andrade tells us why stocks will bounce back strongly and what he's bullish on.

Is It Time to Book Profits in Gold and Silver? (Fast Profits Daily)

Aug 10, 2020

Gold and silver have delivered phenomenal returns this year. Is it time to take some money of the table?

This 20 Year Cycle Suggests Gold is Set for an August Rally (Profit Hunter)

Jul 31, 2020

The real reason why gold prices will go up more.

More

Covid-19 Proof
Multibagger Stocks

Covid19 Proof Multibaggers
Get this special report, authored by Equitymaster's top analysts now!
We will never sell or rent your email id.
Please read our Terms

AUROBINDO PHARMA SHARE PRICE


Aug 10, 2020 (Close)

TRACK AUROBINDO PHARMA

  • Track your investment in AUROBINDO PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON AUROBINDO PHARMA

AUROBINDO PHARMA - ACTAVIS COMPARISON

COMPARE AUROBINDO PHARMA WITH

MARKET STATS